A Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep Pyrosequencing

Autor: St John, Elizabeth P., Simen, Birgitte B., Turenchalk, Gregory S., Braverman, Michael S., Abbate, Isabella, Aerssens, Jeroen, Bouchez, Olivier, Gabriel, Christian, Izopet, Jacques, Meixenberger, Karolin, Di Giallonardo, Francesca, Schlapbach, Ralph, Paredes, Roger, Sakwa, James, Schmitz-Agheguian, Gudrun G., Thielen, Alexander, Victor, Martin, Metzner, Karin J., Daeumer, Martin P., 454 HIV-1 Alpha Study Group

Publikováno v: PLoS ONE
PLoS ONE, Public Library of Science, 2016, 11 (1), pp.Non Paginé. ⟨10.1371/journal.pone.0146687⟩
PLoS One
PLoS ONE, Vol 11, Iss 1, p e0146687 (2016)
Recercat. Dipósit de la Recerca de Catalunya
instname
PLoS ONE, 2016, 11 (1), pp.Non Paginé. ⟨10.1371/journal.pone.0146687⟩
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
PLoS ONE, Public Library of Science, 2016, 11 (1), pp.Non Paginé. 〈10.1371/journal.pone.0146687〉
Plos One 1 (11), Non Paginé. (2016)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
PLoS ONE, 11 (1)

Background Ultra deep sequencing is of increasing use not only in research but also in diagnostics. For implementation of ultra deep sequencing assays in clinical laboratories for routine diagnostics, intra- and inter-laboratory testing are of the ut

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7cfe77bae1d9d486fc92a6bf244fc34
https://hal.archives-ouvertes.fr/hal-01602365

Predictors of mortality and hospitalization for cardiac causes in patients with heart failure and nonischemic heart disease: a subanalysis of the ALPHA study

Autor: Anselmino, M, De Ferrari GM, Massa, R, Manca, L, Tritto, M, Molon, G, Curnis, Antonio, Devecchi, P, Sarzi Braga, S, Bartesaghi, G, Klersy, C, Accardi, F, Salerno Uriarte JA, ALPHA Study Group Investigators

Background: Several studies have searched for predictors of clinical outcome in patients with heart failure (HF). However, since they were collected in clinical trials, most data were subject to selection biases and do not specifically apply to patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81fdec60db5d5b592d69cdf222db7f9e
http://hdl.handle.net/2318/58931

Proportion of patients needing an implantable cardioverter defibrillator on the basis of current guidelines: impact on healthcare resources in Italy and the USA. Data from the ALPHA study registry.

Autor: Pedretti RF, Curnis A, Massa R, Morandi F, Tritto M, Manca L, Occhetta E, Molon G, De Ferrari GM, Sarzi Braga S, Raciti G, Klersy C, Salerno-Uriarte JA, ALPHA Study Group Investigators

Publikováno v: EP: Europace; Aug2010, Vol. 12 Issue 8, p1105-1111, 7p

Rosuvastatin versus atorvastatin in achieving lipid goals in patients at high risk for cardiovascular disease in clinical practice: a randomized, open-label, parallel-group, multicenter study (DISCOVERY Alpha Study)

Autor: Binbrek AS (AUTHOR), Elis A (AUTHOR), Al-Zaibag M (AUTHOR), Eha J (AUTHOR), Keber I (AUTHOR), Cuevas AM (AUTHOR), Mukherjee S (AUTHOR), Miller TR (AUTHOR), DISCOVERY Alpha Study Group (CORPORATE AUTHOR)

Publikováno v: Current Therapeutic Research. Jan2006, Vol. 67 Issue 1, p21-43. 23p.